Search

Your search keyword '"Vlachopoulos, Charalambos"' showing total 148 results

Search Constraints

Start Over You searched for: Author "Vlachopoulos, Charalambos" Remove constraint Author: "Vlachopoulos, Charalambos" Publisher elsevier bv Remove constraint Publisher: elsevier bv
148 results on '"Vlachopoulos, Charalambos"'

Search Results

1. Newly detected diabetes mellitus patients with acute coronary syndrome have an adverse cardiometabolic profile similar to patients with prior diabetes and a more extensive ischemic myocardial insult

2. Comprehensive Angiography-Derived Functional Assessment of Epicardial and Microvascular Coronary Disease. Correlation With Non-invasive Myocardial Stress Imaging

5. Effects of Chios Mastiha essential oil on cholesterol levels of healthy volunteers: A prospective, randomized, placebo-controlled study (MASTIHA-OIL)

7. Exercise and cardiac rehabilitation in hypertensive patients with heart failure with preserved ejection fraction: A position statement on behalf of the Working Group of Hypertension of Hellenic Society of Cardiology

8. 3D printing for ablation planning in patients undergoing atrial fibrillation ablation: Preliminary results of the pilot randomized 3D GALA trial

9. Twenty-first century epidemiology of dyslipidemia in Greece: EMENO national epidemiological study

10. Danon Cardiomyopathy

12. Gender differences in COVID-19

13. Rationale and design of the Hellenic Registry of Clinical events and Adherence to Lipid LowerINg therapy In aCUte coronary Syndrome (CALLINICUS-Hellas Registry)

14. The prognostic impact of the 2015 European Society of Cardiology pericarditis guidelines implementation in clinical practice

15. Permanent pacemaker implantation in unexplained syncope patients with electrophysiology study-proven atrioventricular node disease

16. Biomarkers of Vascular Inflammation for Cardiovascular Risk Prognostication

17. LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments

19. Lipoprotein apheresis: a Hellenic consensus on its clinical use

21. A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States

25. Recurrence of Pericardial Effusion After Pericardiocentesis: Does Catheter-Induced Acute Pericardial Inflammation Play a Role?

26. Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)

27. Arrhythmic risk stratification in nonischemic dilated cardiomyopathy: The ReCONSIDER study design – A two-step, multifactorial, electrophysiology-inclusive approach

28. Acute Idiopathic Pericarditis

29. Proposed algorithm for return to sports in competitive athletes who have suffered COVID-19

30. The impact of transcatheter aortic valve implantation on arterial stiffness and wave reflections

31. Enterococcus faecium purulent pericarditis with transient constriction

32. Clinical characteristics and management of patients with diabetes mellitus and stable coronary artery disease in daily clinical practice. The SCAD–DM Registry

33. Lymphoma Severity and Type Are Associated With Aortic FDG Uptake by 18F-FDG PET/CT Imaging

35. The interplay between aortic arch calcifications and anticoagulation on prognosis of in-hospital complications in acute coronary syndromes

36. Very high-risk familial hypercholesterolaemia patients in real life: The remaining gap in achieving the current LDL-C targets despite the use of PCSK9 inhibitors

37. PCSK9 inhibitors in clinical practice: Novel directions and new experiences

38. The impact of COVID-19 pandemic on adult cardiac surgery procedures

39. Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study

40. Long-Term Outcome of Pericardial Drainage in Cases of Chronic, Large, Hemodynamically Insignificant, C-Reactive Protein Negative, Idiopathic Pericardial Effusions

42. DIFFERENCES IN QUALITY OF LIFE AND FUNCTIONAL STATUS OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY, ACCORDING TO SEX

43. Long-Term Administration of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Reduces Arterial FDG Uptake

45. Predictors of switching from nonsteroidal anti-inflammatory drugs to corticosteroids in patients with acute pericarditis and impact on clinical outcome

46. Editor's Choice – Follow-up of Patients After Revascularisation for Peripheral Arterial Diseases: A Consensus Document From the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery

47. The landscape of acute pericarditis in Greece: Experience from a tertiary referral center

48. Relationship of PCSK9 levels with indices of vascular function and subclinical atherosclerosis in patients with familial dyslipidemias

50. Ankle-brachial index measured by oscillometry is predictive for cardiovascular disease and premature death in the Japanese population: An individual participant data meta-analysis

Catalog

Books, media, physical & digital resources